KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Short term Debt (2019 - 2024)

Historic Short term Debt for Hims & Hers Health (HIMS) over the last 6 years, with Q1 2024 value amounting to $7.4 million.

  • Hims & Hers Health's Short term Debt changed N/A to $7.4 million in Q1 2024 from the same period last year, while for Mar 2024 it was $7.4 million, marking a year-over-year change of. This contributed to the annual value of $7.4 million for FY2023, which is N/A changed from last year.
  • According to the latest figures from Q1 2024, Hims & Hers Health's Short term Debt is $7.4 million.
  • In the past 5 years, Hims & Hers Health's Short term Debt ranged from a high of $42.8 million in Q4 2021 and a low of $404007.0 during Q3 2020
  • Its 5-year average for Short term Debt is $11.1 million, with a median of $7.4 million in 2023.
  • Per our database at Business Quant, Hims & Hers Health's Short term Debt soared by 564371.24% in 2021 and then plummeted by 6318.22% in 2023.
  • Over the past 5 years, Hims & Hers Health's Short term Debt (Quarter) stood at $404007.0 in 2020, then skyrocketed by 10502.29% to $42.8 million in 2021, then tumbled by 69.72% to $13.0 million in 2022, then tumbled by 42.86% to $7.4 million in 2023, then changed by 0.0% to $7.4 million in 2024.
  • Its Short term Debt stands at $7.4 million for Q1 2024, versus $7.4 million for Q4 2023 and $6.9 million for Q3 2023.